NEW YORK (GenomeWeb News) — Epigenomics last week said first-quarter revenue increased 75 percent as R&D spending rose 31 percent and net loss decreased 15 percent.
 
Total receipts for the three months ended March 31, 2007, increased to €820,000 ($1.12 million) from €470,000 ($640,000) year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.